Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor Devices
Open Access
- 6 September 2019
- journal article
- research article
- Published by S. Karger AG in Digital Biomarkers
- Vol. 3 (3) , 103-115
Abstract
Previous studies have demonstrated the feasibility and promise of wearable sensors as objective measures of motor impairment in Parkinson disease and essential tremor. However, there are few published studies that have examined such an application in Huntington disease (HD). This report provides an evaluation of the potential to objectively quantify chorea in HD patients using wearable sensor data. Data were derived from a substudy of the phase 2 Open-PRIDE-HD study, where 17 patients were screened and 15 patients enrolled in the substudy and ultimately 10 patients provided sufficient wearable sensor data. The substudy was designed to provide high-resolution data to inform design of predictive algorithms for chorea quantification. During the entire course of the 6-month study, in addition to chorea ratings from 18 in-clinic assessments, 890 home assessments, and 1,388 responses to daily reminders, 33,000 h of high-resolution accelerometer data were captured continuously from wearable smartwatches and smartphones. Despite its limited sample size, our study demonstrates that arm chorea can be characterized using accelerometer data during static assessments. Nonetheless, the small sample size limits the generalizability of the model. The sensor-based model can quantify the chorea level with high correlation to the chorea severity reported by both clinicians and patients. In addition, our analysis shows that the chorea digital signature varies between patients. This work suggests that digital wearable sensors have the potential to support clinical development of medications in patients with movement disorders, such as chorea. However, additional data would be needed from a larger number of HD patients with a full range of chorea severity (none to severe) with and without intervention to validate this potentially predictive technology.Keywords
This publication has 17 references indexed in Scilit:
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyThe Lancet Neurology, 2019
- Huntington's disease: Current and future therapeutic prospectsMovement Disorders, 2018
- Incorporating Site-less Clinical Trials Into Drug Development: A Framework for ActionClinical Therapeutics, 2017
- A Comprehensive Analysis on Wearable Acceleration Sensors in Human Activity RecognitionSensors, 2017
- Wearable Sensors in Huntington Disease: A Pilot StudyJournal of Huntington's Disease, 2016
- Technology in Parkinson's disease: Challenges and opportunitiesMovement Disorders, 2016
- Detecting Parkinsons' symptoms in uncontrolled home environments: A multiple instance learning approach2012
- Self-awareness of Motor Dysfunction in Patients with Huntington's Disease in Comparison to Parkinson's Disease and Cervical DystoniaJournal of the International Neuropsychological Society, 2011
- A Comparison of Feature Extraction Methods for the Classification of Dynamic Activities From Accelerometer DataIEEE Transactions on Biomedical Engineering, 2008
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996